Peter Nørgaard - Concepedia

Author

Peter Nørgaard

Also Known As

Norgaard, Peter, Nørgaard, Peter, P Nørgaard, P. H. Nørgaard, P. Nørgaard, PETER NØRGAARD, Peter H Norgaard, Peter H. Norgaard, Peter H. Nörgaard, Peter H. Nørgaard

142

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

Herlev Hospital Copenhagen University Hospital Rigshospitalet University of Copenhagen Odense University Hospital

About

Peter Nørgaard is an author at Herlev Hospital specializing in medicine, pathology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	20	2.1K
2	Engineering	2	2	183
3	Health Sciences	1	1	46
4	Natural Sciences	1	1	46
5	Public Health	1	1	33

Peter Nørgaard

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma Anupama Reddy, Jenny Zhang, Nicholas S. Davis, Cell Hematological MalignancyLymphoid NeoplasiaAutoimmune DiseaseMedicineImmunology	2017	1.1K
Mechanical properties of trabecular bone. Dependency on strain rate Frank Linde, Peter Nørgaard, Ivan Hvid, Journal of Biomechanics MechanobiologyEngineeringMechanical PropertiesBiomechanicsMechanical Engineering	1991	168
Loss of the retinoblastoma protein-related p130 protein in small cell lung carcinoma Kristian Helin, Karin Holm, Anita Niebuhr, Proceedings of the National Academy of Sciences	1997	128
<scp>MYC</scp> translocation partner gene determines survival of patients with large B‐cell lymphoma with <scp>MYC</scp>‐ or double‐hit <scp>MYC</scp>/<scp>BCL</scp>2 translocations Mette Ølgod Pedersen, Anne Ortved Gang, Tim Svenstrup Poulsen, European Journal Of Haematology Split ProbesMixed-phenotype Acute LeukemiaImmunologyPathologyImmunotherapy	2013	120
Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements Rebecca A. Luchtel, Surendra Dasari, Naoki Oishi, Blood	2018	112
Double‐hit <scp>BCL</scp>2/<scp>MYC</scp> translocations in a consecutive cohort of patients with large B‐cell lymphoma – a single centre's experience Mette Ølgod Pedersen, Anne Ortved Gang, Tim Svenstrup Poulsen, European Journal Of Haematology Double HitLymphoid NeoplasiaLarge B‐cell LymphomaHematological MalignancyMedicine	2012	98
Salicylate-induced Growth Arrest Is Associated with Inhibition of p70s6k and Down-regulation of c-Myc, Cyclin D1, Cyclin A, and Proliferating Cell Nuclear Antigen Brian K. Law, Mary Waltner‐Law, Amelia J. Entingh, Journal of Biological Chemistry	2000	83
Minimal residual disease and normalization of the bone marrow after long-term treatment with alpha-interferon2b in polycythemia vera. A report on molecular response patterns in seven patients in sustained complete hematological remission Thomas Stauffer Larsen, Michael Møller, Karin de Stricker, Hematology Hematological MalignancyPolycythemia VeraBone Marrow FailureAutoimmune DiseaseMalignant Blood Disorder	2009	82
Glucocorticoids and histone deacetylase inhibitors cooperate to block the invasiveness of basal-like breast cancer cells through novel mechanisms Mark E. Law, Patrick Corsino, Stephan C. Jahn, Oncogene Breast OncologyOncologyMedicineHistone Deacetylase InhibitorsBreast Cancer	2012	79
Malignancy in Crohn's Disease Nina Kvist, O. Jacobsen, Peter Nørgaard, Scandinavian Journal of Gastroenterology April 1964Survey Period 23January 1983Gastrointestinal OncologyMedicine	1986	77

Page 1